Nouscom Announces Promotion of Richard Davis to Chief Operating Officer

News
2022
2021
Archive

May 23, 2022

Nouscom Announces Promotion of Richard Davis to Chief Operating Officer
May 23, 2022

Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear at the American Society of Gene and Cell Therapy 25th Annual Meeting
May 18, 2022

Homology Medicines Presents Details of Optimized HMI-103 Nuclease-Free Gene Editing Candidate Featuring Integrated Liver-Specific Promoter to Maximize Long-Term Expression
May 17, 2022

scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application
May 17, 2022

Nouscom Announces Janssen Receives U.S. FDA IND Clearance for VAC85135, an “Off-The-Shelf” Cancer Immunotherapy Developed Using Nouscom’s Proprietary Viral Vector Platform
May 11, 2022

Entrada Therapeutics Presents New Data Supporting its Growing Pipeline of Endosomal Escape Vehicle (EEV™) Therapeutics at TIDES USA 2022
May 10, 2022

Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
May 10, 2022

NodThera Announces Clinical Progress for Lead NLRP3 Inflammasome Inhibitors and Candidate Selection of Novel Brain-Penetrant Compound
May 10, 2022

Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients with Innovative Needle-Free Drug-Delivery Solution
May 3, 2022

GlycoEra AG Appoints Ganesh V. Kaundinya as President and Chief Executive Officer

1
2
3
…
91
Next Page »

© 2022 5AM Venture Management LLC